No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
www.hcahealthcare.comNo one on the platform currently holds 0J1R.L.
No tracked institution reports a position in 0J1R.L as of their last filing.
No one on the platform has traded 0J1R.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 21.3% | 25.9% | 21.5% | — | — | — |
| Rev. Growth % | 7.1% | 8.0% | ||||
| Profit Margin % | 9.0% | 9.3% | 8.1% | |||
| Free Cash Flow Margin % | 10.2% | 8.3% | 8.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $78.5B | +3.7% | $29.47 | $28.67–$29.99 | — | 1 |
| 2027 | $81.5B | +3.8% | $32.09 | $31.21–$32.66 | — | 1 |
| 2028 | $85.3B | +4.6% | $35.34 | $34.38–$35.97 | — | 1 |
| 2029 | $91.0B | +6.7% | $39.24 | $38.17–$39.94 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-24 | $7.56 | $7.59 | +0.4% |
| 2026-04-24 | $7.12 | $7.15 | +0.4% |
| 2026-01-27 | $7.46 | $8.01 | +7.4% |
| 2025-10-24 | $5.79 | $6.96 | +20.2% |
| 2025-07-25 | $6.29 | $6.84 | +8.7% |
| 2025-04-25 | $5.75 | $6.45 | +12.2% |
| 2025-01-24 | $6.13 | $6.22 | +1.5% |
| 2024-10-25 | $4.96 |
| $4.89 |
| -1.4% |
| +2.92% |
| $111.6B |
| — |
| 0LJL.LUniversal Health Services, Inc. | $170.88 | -2.13% | $10.5B | — |
| 0QZU.LVertex Pharmaceuticals Incorporated | $519.86 | +0.23% | $132.9B | — |
Source: Financial Modeling Prep · peers by sector/industry